Literature DB >> 15672542

Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.

Rukhsana Sultana1, D Allan Butterfield.   

Abstract

Alzheimer disease (AD) is a neurodegenerative disorder characterized pathologically by intracellular inclusions including neurofibrillary tangles (NFT) and senile plaques. Several lines of evidence implicate oxidative stress with the progression of AD. 4-hydroxy-2-trans-nonenal (HNE), an aldehydic product of membrane lipid peroxidation, is increased in AD brain. The alpha class of glutathione S-transferase (GST) can detoxify HNE and plays an important role in cellular protection against oxidative stress. The export of the glutathione conjugate of HNE is required to fully potentiate the GST-mediated protection. The multidrug resistance protein-1 (MRP1) and GST proteins may act in synergy to confer cellular protection. In the present study, we studied oxidative modification of GST and MRP1 in AD brain by immunoprecipitation of GST and MRP1 proteins followed by Western blot analysis using anti-HNE antibody. The results suggested that HNE is covalently bound to GST and MRP1 proteins in excess in AD brain. Collectively, the data suggest that HNE may be an important mediator of oxidative stress-induced impairment of this detoxifying system and may thereby play a role in promoting neuronal cell death. The results from this study also imply that augmenting endogenous oxidative defense capacity through dietary or pharmacological intake of antioxidants may slow down the progression of neurodegenerative processes in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672542     DOI: 10.1007/s11064-004-7028-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

Review 1.  Carbonyl toxicology and Alzheimer's disease.

Authors:  Matthew J Picklo; Thomas J Montine; Venkataraman Amarnath; M Diana Neely
Journal:  Toxicol Appl Pharmacol       Date:  2002-11-01       Impact factor: 4.219

Review 2.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

3.  Impaired proteasome function in Alzheimer's disease.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

4.  The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins.

Authors:  R Subramaniam; F Roediger; B Jordan; M P Mattson; J N Keller; G Waeg; D A Butterfield
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

5.  Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

Authors:  R J Mark; Z Pang; J W Geddes; K Uchida; M P Mattson
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

6.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

7.  Role of alpha class glutathione S-transferases as antioxidant enzymes in rodent tissues.

Authors:  Yusong Yang; Rajendra Sharma; Piotr Zimniak; Yogesh C Awasthi
Journal:  Toxicol Appl Pharmacol       Date:  2002-07-15       Impact factor: 4.219

8.  Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells.

Authors:  C S Morrow; P K Smitherman; S K Diah; E Schneider; A J Townsend
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

9.  4-Hydroxyalk-2-enals are substrates for glutathione transferase.

Authors:  P Alin; U H Danielson; B Mannervik
Journal:  FEBS Lett       Date:  1985-01-07       Impact factor: 4.124

10.  Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.

Authors:  K Uchida; S Toyokuni; K Nishikawa; S Kawakishi; H Oda; H Hiai; E R Stadtman
Journal:  Biochemistry       Date:  1994-10-18       Impact factor: 3.162

View more
  44 in total

Review 1.  Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Jacqueline R Kulbe; Edward D Hall
Journal:  Exp Neurol       Date:  2020-04-20       Impact factor: 5.330

Review 2.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

3.  Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Tanea T Reed; Marzia Perluigi; Carlo De Marco; Raffaella Coccia; Jeffrey N Keller; William R Markesbery; Rukhsana Sultana
Journal:  Brain Res       Date:  2007-03-07       Impact factor: 3.252

Review 4.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

Review 5.  Elevation of glutathione as a therapeutic strategy in Alzheimer disease.

Authors:  Chava B Pocernich; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2011-10-12

6.  Natural vitamin E α-tocotrienol protects against ischemic stroke by induction of multidrug resistance-associated protein 1.

Authors:  Han-A Park; Natalia Kubicki; Surya Gnyawali; Yuk Cheung Chan; Sashwati Roy; Savita Khanna; Chandan K Sen
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

Review 7.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

8.  Effects of Phenelzine Administration on Mitochondrial Function, Calcium Handling, and Cytoskeletal Degradation after Experimental Traumatic Brain Injury.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2018-12-12       Impact factor: 5.269

Review 9.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

Review 10.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.